Nemaura Medical Inc.
NMRD
NSC
Sector: Healthcare
Industry: Medical Devices
2.18
USD
0.14
(6.86%)
Optionable: Yes Market Cap: 46 M 90-day average vol: 9,409
Previous close: 2.04 Open: 2.33 Bid: 2.24 Ask: 2.24
52 week range
1.70 7.88
Last updated: Friday 5th August 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Metrics
Valuation
Price per Sales TTM ($) | 90.41 |
Price per Book TTM ($) | 103.25 |
PE Ratio (TTM) | -3.40 |
Book Value per Share ($) | 0.02 |
5 Year PE Range | -27.1 , -28.2 |
Returns
7 Day Return | 11.79% | |
1 Month Return | -0.91% | |
3 Month Return | -37.89% | |
1 Year Return | -69.60% | |
3 Year Return | -75.23% | |
5 Year Return | -96.21% | |
YTD Return | -52.19% |
Risk
Custom Beta One Year | -23.24 |
Custom Beta Three Years | -23.24 |
Beneish M Score | 0.00 |
Altman Z Score | 0.49 |
Analyst Estimates
Financial Health
Technicals
RSI (14 Day) | 53.94 |
14 Day SMA ($) | 1.94 |
14 Day EMA ($) | 2.00 |
Money Flow Index | 36.12 |
Average True Range | 0.16 |
50 Day SMA ($) | 2.37 |
200 Day SMA ($) | 3.90 |
ADX | 26.99 |
MACD | -0.09 |
Growth
Free Cash Flow QoQ Growth | -48.35% |
Free Cash Flow YoY Growth | 0.00% |
Revenue YoY Growth | 0.00% |
EPS QoQ Growth | 0.00% |
Revenue QoQ Growth | 0.00% |
EPS YoY Growth | 0.00% |
Profitability
Return on Assets TTM (%) | -50.15 |
Profit Margin TTM (%) | -1502.3 |
Return on Equity TTM (%) | -332.28 |
Return on Capital TTM (%) | -43.58 |
Interest Coverage Ratio | -1.10 |
Gross Margin TTM (%) | 31.7 |
Chart
News
Nemaura Medical Wins Innovation Awards
Yahoo Finance 2/28/2022
Nemaura Medical GAAP EPS of -$0.15, revenue of $0.18M
Seeking Alpha 2/14/2022
Nemaura Medical Announces Fiscal Third Quarter 2022 Financial Results and Provides Business Update
Yahoo Finance 2/14/2022
Nemaura Medical Launches Metabolic Health Program for Employers and Insurers
Yahoo Finance 1/13/2022
Nemaura Medical Appoints Dr. Arash Ghadar as Chief Operating Officer
Yahoo Finance 1/10/2022
Nemaura Medical to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference
Yahoo Finance 1/7/2022
Nemaura Medical Completes Initial Shipment of CGM Devices to UK Licensee
Yahoo Finance 12/7/2021
Nemaura Medical to Present at the Benzinga Global Small Cap Conference
Yahoo Finance 11/30/2021
Nemaura Medical EPS misses by $0.04
Seeking Alpha 11/15/2021
Nemaura Medical Announces Fiscal Second Quarter 2022 Financial Results and Provides Business Update
Yahoo Finance 11/15/2021
Nemaura Medical to Present at the Diabetes Technology Society 2021 Conference on November 4, 2021
Yahoo Finance 11/3/2021
Is Nemaura Medical (NASDAQ:NMRD) A Risky Investment?
Yahoo Finance 10/25/2021
Nemaura Medical Inc. Announce Beta Launch of Proprietary 'MiBoKo' Metabolic Health Program
Yahoo Finance 10/19/2021
Nemaura Medical Inc. Harnesses the Power of Patient-Provider Communication
Yahoo Finance 10/6/2021
Nemaura Medical to Present at the LD Micro Main Event Conference
Yahoo Finance 10/5/2021
Trend Analysis & Forecast
Read more on this trend analysis & forecast here - uptrenddowntrend.com
Trendlast: -2.105
Financials
NMRD Income Statement
Annual
| Invalid date | Dec-13 | Mar-14 | Mar-15 | Mar-16 | Mar-17 | Mar-18 | Mar-19 | Mar-20 | Mar-21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cost of sales | -1141 | -5099 | -7556 | -17404 | -20433 | -29256 | -33407 | -54840 | -98075 | |
| Gross operating profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Selling Gen & administrative expense | 167750 | 202376 | 495337 | 511413 | 516661 | 915132 | 2 M | 3 M | 3 M | |
| Research & development expense | 172446 | 383857 | 824503 | 1 M | 1 M | 993833 | 2 M | 2 M | 2 M | |
| Operating income | -340196 | -586233 | -1 M | -2 M | -2 M | -2 M | -4 M | -5 M | -5 M | |
| floaterest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| floaterest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Other income net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Pre-tax Income (EBT) | -340196 | -586233 | -1 M | -2 M | -2 M | -2 M | -4 M | -5 M | -7 M | |
| Income taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -614362 | -335832 | |
| Net income from total operations | -340196 | -586233 | -1 M | -2 M | -2 M | -2 M | -4 M | -4 M | -6 M | |
| Minority floaterest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Total net income | -340196 | -586233 | -1 M | -2 M | -2 M | -2 M | -4 M | -4 M | -6 M | |
| Preferred dividends | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| Net income available for common | -340196 | -586233 | -1 M | -2 M | -2 M | -2 M | -4 M | -4 M | -6 M | |
| Depreciation | 1141 | 5099 | 7556 | 17404 | 20433 | 29256 | 33407 | 54840 | 98075 | |
| Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Operating income before depreciation (EBITDA) | -339055 | -581134 | -1 M | -2 M | -2 M | -2 M | -4 M | -5 M | -4 M | |
| Total Income available for floaterest expense (EBIT) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Basic EPS total | -0.02 | -0.03 | -0.07 | -0.08 | -0.08 | -0.1 | -0.25 | -0.2 | -0.28 | |
| Diluted EPS total | -0.02 | -0.03 | -0.07 | -0.08 | -0.08 | -0.1 | -0.25 | -0.2 | -0.28 |
Top MarketXLS Rank stocks
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started today
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!